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Abstract
Background: Person-centred care (PCC) focusing on personalised goals and care plans derived from “What matters
to you?” has an impact on single disease outcomes, but studies on multi-morbid elderly are lacking. Furthermore,
the combination of PCC, Integrated Care (IC) and Pro-active care are widely recognised as desirable for multi-
morbid elderly, yet previous studies focus on single components only, leaving synergies unexplored. The effect of a
synergistic intervention, which implements 1) Person-centred goal-oriented care driven by “What matters to you?”
with 2) IC and 3) pro-active care is unknown.
Methods: Inspired by theoretical foundations, complexity science, previous health service research and a patient-
driven evaluation of care quality, we designed the Patient-Centred Team (PACT) intervention across primary and
secondary care. The PACT team collaborate with the patient to make and deliver a person-centred, integrated and
proactive multi-morbidity care-plan. The control group receives conventional care. The study design is a pragmatic
six months prospective, controlled clinical trial based on hospital electronic health record data of 439 multi-morbid
frail elderly at risk for emergency (re) admissions referred to PACT and 779 propensity score matched controls in
Norway, 2014–2016. Outcomes are emergency admissions, the sum of emergency inpatient bed days, 30-day
readmissions, planned and emergency outpatient visits and mortality at three and six months follow-up.
Results: The Rate Ratios (RR) for emergency admissions was 0,9 (95%CI: 0,82-0,99), for sum of emergency bed days
0,68 (95%CI:0,52-0,79) and for 30-days emergency readmissions 0,72 (95%CI: 0,41-1,24). RRs were 2,3 (95%CI: 2,02-2,
55) and 0,9 (95%CI: 0,68-1,20) for planned and emergency outpatient visits respectively. The RR for death at 3
months was 0,39 (95% CI: 0,22-0,70) and 0,57 (95% CI: 0,34-0,94) at 6 months.
Conclusion: Compared with propensity score matched controls, the care process of frail multi-morbid elderly who
received the PACT intervention had a reduced risk of high-level emergency care, increased use of low-level planned
care, and substantially reduced mortality risk. Further study of process differences between groups is warranted to
understand the genesis of these results better.
Trial registration: ClinicalTrials.gov (identifier: NCT02541474), registered Sept 2015.
Keywords: Person-centred care, Integrated care, Proactive care, Health care utilisation, Mortality, Propensity score
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Background
A rising number of elderly citizens heralds an increased
number of persons with complex long-term needs
(CLNs) who need and expect more of our care systems.
Persons with CLNs typically face multiple care providers,
organisations and specialists [1], and are especially vul-
nerable to care fragmentation [1–4]. This group also
dominates the 5–10% top spenders who account for 2/3
of high-level health care spending both in Norway and
internationally [5–7]. The expected increase in persons
with CLN is threatening the sustainability of our health-
care systems [8]. Current care systems, designed for
acute short-term needs, are struggling to meet the rising
tide of persons with CLNs.
An extensive body of research indicates that critical el-
ements of high-quality care for persons with CLNs in-
clude strong primary care with an inherent whole
person, integrated and pro-active focus [9–14]. For sim-
plicity, we will nickname this three-part solution PIP
care, for Person-centred care (PCC), Integrated Care
(IC) and Proactive care (Pro-C). There is an abundance
of generally promising reviews regarding each of these
three elements [15–24]. Yet, outcome evaluations re-
main unpredictable or weak with a high proportion of
negative studies [15–22]. Reviewers report that there is
little conceptual clarity on how to operationalise the
PIP-elements, and for whom and in which contexts they
will work [16, 17, 25]. We propose that the PACT study
differs from previous research in two regards:
A synergistic approach
Even though international recommendations highlight
the complex and multi-faceted synergies between these
three PIP-elements, studies in this field have generally
followed the traditional approaches of the “rational-lin-
ear” approach, “… When designing intervention and im-
plementation strategies, as well as when conducting
rigorous evaluations, there is a tendency to reduce messy
real world situations into the individual component parts
in an attempt to determine the relationships between
them” [20, 26]. However, to achieve better outcomes for
persons with CLNs, the whole chain of care needs to
change. We propose that the PIP-components are inter-
dependent, and will only produce the expected effects if
all the components are in place. The effect of an inter-
vention where the PIP elements work synergistically to-
gether is mostly unexplored.
A sharper definition of PCC
PCC is in many ways the foundation of PIP-care. PCC is
widely recognised as desirable [13, 15, 27] yet the gap be-
tween the rhetoric and reality of PCC remains uncomfort-
ably wide [28, 29]. The last few years, a sharper vision of
PCC described by Bisognano as “flipped healthcare” is
emerging [15, 30, 31]. It flips care focus from: What is the
matter?" to “What matters to you?” It forces attention from
professionally defined diagnosis and functional goals to per-
sonal goals. Here, we prefer the term “Goal-oriented Per-
son-centred care” (Goal-PCC), to underline that in “flipped
care,” the entire chain of care, including care planning, de-
livery, and evaluation is co-created with the person and
driven by personal goals [32]. While Coulter found in her
Cochrane review that Goal-PCC had a small but significant
impact on outcomes in single disease contexts, neither
Coulter nor we have found any studies that applied this
concept to multi-morbid patients [15].
Norway has a robust primary care system [33], with
high accessibility and low out of pocket expenses,
among the highest life expectancies in the world, and
excellent health outcomes in international compari-
sons, and a commitment to quality improvement for
persons with CLNs [34–39]. However, persons with
CLNs in Norway report the same challenges as other
high-income countries, making the Norwegian context
internationally relevant [39–41].
We designed the PACT intervention to address quality
challenges identified by patients with CLNs in Norway
[41], in alignment with the theoretical and empirical foun-
dations of chronic care ideals. Central ideals were the
Chronic Care Model [42], Goal-oriented Person-centred
care [15, 31, 41, 43, 44], Shared Decision Making [45],
integrated care pathways [46] and pro-active risk
management [23, 47]. We were mindful of the complex
nature of both the health service and the PACT interven-
tion [48–50]. The care process for each person, here
denoted as the individualised Patient Pathway (iPP) [41],
is a product of a complex adaptive system (CAS) [49]. Key
elements to support problem-solving in a CAS are: A
good enough vision or goal, simple guiding rules and a
wide space for innovation and creativity to reach common
goals [49]. The goals and rules were set out in our previ-
ous work on the Person-centred integrated care quality
framework [41]. Briefly, the iPP serves patient-defined
goals [31, 44], with attention to PCC, IC and Pro-C, while
incorporating insights and feedback from both the patient
and other contributors is an ongoing attribute of the care
process [48]. To the best of our knowledge, we have not
found other studies on the effects of a complex, synergistic
and “flipped” Goal-PCC model, which builds all three PIP-
elements into the care model the way our Patient-Centred
Team (PACT) intervention does.
Aim
The PACT study aims to improve the triple aim of pa-
tient care experience, health outcomes and cost-benefit
ratios for persons with CLNs. Due to delays in the col-
lection of patient reported outcomes (see details later),
we here report on early and available health outcomes
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using routine data from the electronic health record
(EHR). We expect that the PACT intervention applied
to a population of high risk frail multi-morbid elderly
will stabilize the patient’s health situation through im-
proved quality of care. As a result, we expect to see a re-
duced use of high-level emergency care and a higher use
of low-level planned care. Hypothetically, use of emer-
gency care could be reduced simply by denying patients
adequate care. This would of course be unethical, and in
this frail group, we would expect increased mortality.
We therefore needed to show that reductions in the use
of high-level emergency care was not accompanied by
increased mortality. To summarize, the hypotheses (H)
examined in this paper are that the PACT intervention
will cause:
 H1: Reduced use of high-level emergency care .
 H2: Increased use of low-level planned care
 H3: Unchanged mortality risk
Methods
Study design, reporting and protocol changes
This study is a prospective propensity score (PS)
matched controlled trial evaluating the effectiveness of
the PACT service. Briefly, the use of routine data from
the EHR, and the propensity score techniques described
by Rubin [51–53], allowed us to create a valid compari-
son group even when the target population was defined
by a discretionary referral process. The same EHR data
also contained relevant process and outcome measures,
which enabled a comparison of intervention and usual
care. We follow recommendations for evaluation of
complex interventions [54], complexity science [55] and
quality improvement methodology [56].
The study design, which has been called a synthetic
RCT, lies somewhere between the randomized controlled
trial (RCT) and the observational study. We adhere to the
CONSORT [57] STROBE [58], TIDieR [59] and the
SAMPL [60] checklists for reporting on RCT, observa-
tional, intervention and biostatistical studies respectively.
We have previously published our study protocol
at ClinicalTrials.gov (identifier: NCT02541474) and
as a protocol paper [61]. We found it necessary to
make the following protocol changes: 1) Due to
delays in data collection, we report on secondary
health outcomes before we are able to report on the
primary outcome: the patient reported health experi-
ence by the SF12 questionnaire [62]. 2) Due to a
high risk of healthy selection bias, we were allowed
to include routine EHR data on all patients receiving
PACT without their consent, while the original
protocol planned inclusion based on written in-
formed consent.
The arguments for these two changes are
Patients, who had consented to receive care (care consent)
from the PACT team, were eligible to be invited to give
their informed written consent to participate in the PACT
study (study consent). However, a high proportion suf-
fered from acute serious or overwhelming morbidity at
baseline. It is unethical to ask patients to fill a study con-
sent or questionnaire in a situation where treatment and
adjustment should take precedence. When patients had
recovered sufficiently for study recruitment to be ethical,
many were already past the 4 week study recruitment win-
dow and were no longer eligible. 2) A high proportion of
persons with cognitive impairment were unable to provide
informed consent and we found that family members were
frequently uncomfortable answering personal questions
on the patient’s behalf. For these two reasons, the recruit-
ment and collection of the primary outcome based on pa-
tient reported data is delayed, is still ongoing and will
continue to March 2019.
As early results on secondary health outcomes were
important for health service decision makers regarding
the funding of the PACT service, we looked for other
ways to evaluate the PACT service. We also feared that
a study based on informed consent would be flawed by a
healthy selection bias. With this background, we sought
and were granted permission (see ethics section) to ex-
tract routinely collected data from the EHR which con-
tains both exposure and outcomes variables for both the
intervention and control population, without asking for
patient consent. This would ensure fair recruitment, ir-
respective of challenges to provide consent. The main
ethical concern of this approach was to maintain privacy
of the routine data provided to the research team. The
privacy protection officer approved the project with the
following precautions to ensure the privacy of the partic-
ipants: We prepared pseudonymised analysis files, which
means that direct identifiers such as names, addresses or
id-numbers, were replaced with a pseudonym. We saved
and used analysis files exclusively on “offline” devices/
computers. Only 3 researchers (GB, JH, TB1) had access
to the analysis files. All intermediate and final analysis
results are fully anonymous.
We, are therefore able to report here on the outcomes
available to us from the EHR: healthcare utilisation and
risk of death.
The intervention design
The intervention was tailored to each patient, as long as
the PACT team adhered to the following structures and
principles.
The PACT structures
The PACT team is a cross-organisational (hospital and
municipality) multi-disciplinary geriatric team set in two
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separate municipalities (M1 and M2), both with more
than 20,000 inhabitants in Norway. Both M1 and M2
provide typical primary care services, and both host a
local hospital. The local PACT team includes nurse co-
ordinators, physio- and occupational therapists, geriatric
nurses, pharmacists, medical secretaries and a medical
doctor. The hospital and municipalities share financial,
management and employment responsibilities for the
team members. The PACT board represented significant
stakeholders: Patients, primary and secondary care, re-
search and health technology.
PACT care process
We designed PACT in a heuristic iterative process
cycling between literature reviews [31], listening to
and addressing patient [41], professional and manager
experiences. PACT has many of the same components
as other interventions directed at frail elderly persons:
PACT is person-centred, applies a comprehensive
geriatric assessment methodology to create an evi-
dence-based care plan. PACT applies a combination
of a case manager and a multi-professional team to
address complex patient issues in line with inter-
national guidelines [11, 12]. However, PACT differs
from the bulk of integrated care research in two crit-
ical respects:
1. The vision of a Goal-oriented PCC: The heart of
the PACT intervention is a continuous process of
trust-building, sensitive exploration and co-
creation between professional and patient, aimed
at capturing “What matters to you?”. Together
with the person, PACT translates “What matters”
into relevant goals for care and makes sure that
all involved parties are aware of personal goals,
and that each person’s role relative to goals, is
clear. Theoretically, this aligns with quality
improvement projects and complexity science
where goals/ vision define subsequent plans,
process and evaluation [49, 56].
2. The synergetic cyclical care process: In the
PACT intervention, the three PCC, IC and Pro-C
elements synergistically build on each other. We
hypothesise that Pro-C is most influential for
health and functional outcomes, and that Pro-C
relies on the presence of Goal-PCC and IC to
achieve effects. The design of a care plan follows
a cyclical pattern in line with quality
improvement and complexity theory: The
development of goals, care plan and delivery
continuously adjust to new insights and feedback
from the involved parties. The care process is
described in more detail elsewhere (Additional
file 1 – the PACT care process). Briefly, the
PACT team supports usual care in the creation
of a goal-oriented, person-centred, integrated and
pro-active care plan according to the following
simple rules.
1) PCC, where “what matters” to the person drives
decision making of the care plan.
2) IC includes comprehensive care planning by a
multi-disciplinary, cross-organisational care
team, designed to meet goals from 1. The
process involves the person, the PACT mini-
team (see below) and the informal and formal
long-term carers who will take over when
PACT withdraws. It results in a negotiated
care plan, which sets out the overarching
personal goals (what matters), and then
outlines roles and responsibilities for the
long-term team: who does what, when, and
why. PACT is mindful that a strong care plan
ownership by both patient and the most
involved health workers is essential for long-
term success after PACT withdrawal.
3) Pro-C includes risk management and
preparation for early release to as low-level
care as possible while ensuring that adequate
evidence-based guidelines, such as
comprehensive geriatric assessment [63],
have been reviewed. If possible and desirable,
PACT implements guidelines for the range of
conditions present. Included in the team’s
repertoire are support for self-management,
emergency contingency plans, diagnosis
specific monitoring tools (i.e. signs of
infection in COPD patients, weight increase
in heart failure patients), and the “bow-tie”
analysis [47]. To be included in the care
plan, pro-active measures must align with
personal goals from 1 and the advice of the
multi-disciplinary team from 2.
4) Continuous evaluation of both care planning
and delivery, together with the person, to
ensure dynamic learning and adjustment of the
process in accordance with “what matters”. The
patient’s feedback regarding the realisation of
“what matters” is the guiding principle.
5) PACT starts the delivery of care while usual
care resources are still being assembled/trained.
PACT aspires to a gradual handoff of care
delivery to self-management and usual care as
soon as possible. PACT revisits the patient and
his/ her care team for up to 3 months after
withdrawal. If significant gaps in planned care
occur during this time, PACT either temporarily
fills the gap or re-assesses the plan to set it on
course again.
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A core team consisting of a nurse coordinator, a
physician and a secretary review all referrals. Patients
admitted to the intervention are assigned a PACT
mini-team consisting of a nurse, physician, physio-
therapist, occupational therapist and pharmacist. One
of these takes on the role as the primary coordinator
of the patient pathway for the duration of PACT
involvement. The mini-team have the freedom to “in-
vent” the best possible care plan together with the
person in question, as long as they are loyal to the
above principles. Their work will consist of exploring
patient goals, initiating diagnostic work-ups and other
relevant evaluations, addressing the immediate clinical
needs of the patient, and starting the coordination
work regarding identifying and recruiting the usual
care resources that need to be involved in long-term
care planning and delivery when PACT withdraws.
Handoff is thus a longitudinal collaborative process,
where PACT works together with the patient and
usual care to support them while a long-term care
plan/ delivery comes into place. The average active
PACT intervention time was 30 days.
PACT has a daily meeting involving all PACT em-
ployees, across the mini-teams, where the team
members discuss both challenges at patient and sys-
tem level. The PACT team project leader reports
regularly on system level challenges to the PACT
cross-organizational board.
Data sources and quality
The study extracted following variables for eligible
populations in the four intervention and control mu-
nicipalities from the EHR: Age, sex, start and stop
time of outpatient, ambulatory care and inpatient
episodes of care, degree of emergency for each
episode, ICD-10 diagnoses and Diagnosis Related
Group (DRG)-codes registered for each episode [64],
DRG-points and date of death. Professionals collect
these variables as a matter of routine care for all
patients. The local hospital, which supplied our
EHR-data, provides 97% or more of all out-patient
and in-patient hospital services for the local popula-
tion [65]. All Norwegian hospitals report these data
routinely to the Norwegian Patient Registry (NPR).
NPR consistently assesses data quality and corrects
errors in the source data in collaboration with the
source institution [65]. The EHR is updated with
mortality data from the Norwegian Population
Registry (PR) on a monthly basis, including all
deaths (i.e. deaths at home, hospital or other institu-
tions) in the study population. It takes approximately
one week from when the physician issues a death
certificate until the PR is updated (personal commu-
nication from PR).
Patients
Intervention patients – index episode
The analysis includes all patients who consented to
(care consent), and were offered treatment by the
PACT team from Oct 2014 and Sept 2015 in M1
and M2 respectively until March 2016, with a 6-
month follow-up, ending in Sept 2016. As there is
no agreed method of identification of patients with
CLNs, PACT applied the following recruitment
process. General practitioners, home-nursing
services, hospital specialists or hospital nurses were
encouraged to refer community-dwelling or hospita-
lised patients with multi-morbidity, complex long-
term care needs and high short-term risk for
emergency hospital (re-)admission based on their
professional discretion (i.e., a clinical crisis).
 Inclusion criteria: Patients living in M1 or M2, aged
> 60 years, referred to a PACT-team to be reviewed
for eligibility to receive PACT care and the patient
provided an oral consent, recorded in the EHR, to
receive PACT care (care consent).
 Exclusion criteria: The PACT team reviewed all
referrals, and declined patients who had an adequate
care plan, or were in no need of a multi-disciplinary
follow-up. PACT declined these referrals within < 24
h. They received no PACT services.
Control patients – index episode
All PACT referrals are indicative of a clinical crisis in a per-
son with multi-morbidity. Patients > 60 years, who experi-
enced a clinical crisis as evidenced by an emergency
admission (index episode), were eligible as controls.
Controls were recruited from the pool of similar patients
who had not received PACT care in the PACT intervention
municipalities (M1, M2), and from two control municipal-
ities (M3 and M4), where the PACT intervention was un-
available. M3 and M4 had a similar population size and
local health care structure to M1 and M2 respectively.
Controls received usual care. Usual care consists of
evidence based care for the cause of emergency admis-
sion to hospital. Depending on the patient’s condition,
care for other diagnoses is either achieved through refer-
rals to the appropriate in-house specialist service, or
through a recommendation for follow-up in the dis-
charge letter directed at the GP. Care-coordination and
integration at discharge is achieved through standard
electronic communication and discharge routines de-
signed in collaboration by the hospital and municipal
care organizations.
Analyses
We followed intention to treat principle, as we included
all patients who were offered and gave their consent to
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receive services from PACT services in analyses, inde-
pendent of the actual length, content, and delivery of
PACT services.
Power, modelling decisions and statistical significance
We made apriori power calculations for emergency admis-
sions. These indicated a need for at least 390 patients in
each group to show a 20% reduction in emergency
admissions, (β of 80% and α of 0,05%). We based power cal-
culations on Norwegian hospital admissions data of pa-
tients with at least one admission last year (location
parameter μ = 0.5 and scale parameter σ=1.1, non-paramet-
ric Wilcoxon two-sample test). [66]
To minimise type I error, we based analytic modelling de-
cisions on the size of results rather than statistical signifi-
cance, reserving statistical tests for evaluation of outcomes.
We considered a change in point-estimates > 10% to signify
a large enough confounding effect to warrant adjustment
for the variable in the statistical model [67, 68]. Similarly,
we considered a 10% difference in effects between a main
analysis and a sensitivity (sub-group) analysis to be large
enough to warrant separate consideration in Results. We
defined a probability of < 0,05 as statistically significant. We
report both exact p-values and 95% confidence intervals to
reflect the statistical uncertainty of point estimates. The
95% CI also conveys statistical significance at the chosen
significance level, as a 95% confidence interval for a RR
which includes 1 means that the null-hypothesis was not
rejected. There were no interim analyses planned.
Outcome measures
We expected the PACT intervention to have its main ef-
fect through its Pro-C component, which prevents the
need for emergency care. In the absence of increased
mortality, we interpret less use of emergency resources
as an indicator of better health and function. We
hypothesised that increased use of planned care events
at the lowest effective level of care would be instrumen-
tal in the reduction of high-level emergency care. Al-
though death is the ultimate health outcome, we did not
expect a substantial effect on mortality, as the literature
did not support this [16]. We monitored deaths mainly
to ensure that the mortality experience in the two
groups was comparable and that the expected reductions
in care utilisation was not attributable to increased mor-
tality. Based on these expectations, we chose the follow-
ing outcome measures within the observation period.
Outcome measures by hypotheses were:
H1: We expect a reduced utilisation of high-level
emergency care.
 Count of emergency admissions (defined as care
required within 24 h) – reflects the number of
emergencies that could not be solved by municipal
care.
 Sum of emergency in-patient bed days – is a
composite measure reflecting both number of
emergencies and length of stay resulting from each
emergency.
 Count of re-admissions (emergency admissions
within 30 days of last discharge) – is a measure of
the quality of the discharge arrangements of the
previous hospitalisation.
H2: Increased utilisation of low-level and planned care:
 Count of planned out-patient visits
 Count of emergency out-patient visits
H3: No change in mortality risk:
 Mortality risk at three and six months follow-up
The follow-up started at the time of the first referral
to PACT (intervention) or at the time of emergency ad-
mission (controls) and ended at six months follow-up or
death. Administrative personnel recorded outcomes as a
matter of routine and were blind to group allocation.
Matching, propensity score, and balance
This is parallel arm study, with a 1:2 intervention-con-
trol ratio. We identified both a local (same municipality)
and a distant control from a similar municipality without
PACT services, for each intervention patient. In the
pooled data, we worked with matched triplets: The inter-
vention patient + their local + distant control.
Within the eligible control populations, we performed
exact matching on sex, intervention-control site and year of
the episode. Within these constraints, we identified controls
with a propensity score of +/− 0,2 SD calliper of the inter-
vention patient’s score using MatchIt software following
the methodology laid out by Rubin and Rosenbaum [51, 52,
69, 70]. We used the following variables with a theoretical
link to outcomes to build the propensity score: [71, 72]
Demographic variables (age, sex), last year’s care-utilisation
variables, last two year’s morbidity variables and risk scores
reflecting resource utilisation, re-admission risk [73], and
mortality.[77] Three per cent of intervention patients
lacked hospital visits last year so we could not construct
their propensity scores. Within callipers, we matched on
Mahalanobis distance (MD) on the three variables that
were most unbalanced after PS-matching, as recommended
by Rubin [53]. We provide balance statistics in line with
recommendations by Rubin [53].
Regression analyses
The purpose of regression analyses is to provide an as
unbiased estimate of the main effect of treatment vari-
able as possible. Even when there is an excellent bal-
ance, there may be residual confounding, which may
require additional multivariate adjustment analyses of
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the matched dataset. In agreement with the data fit, we
chose negative binomial regression for our count vari-
ables (sum bed days, admissions and outpatient visits)
[75] and Cox regression for mortality risk. Using
Kaplan Meier (KM) plots and proportional hazards
(PH)-test, [76] we found the PH assumptions to be vio-
lated at 4–6 months, although the KM-lines did not
cross (See Fig. 2). We report RRs for both 0–3 months
and 0–6 months. Readers should interpret the latter as
an average RR for the full period. We chose robust esti-
mations of standard errors in line with recommenda-
tions [75].
Exposure variables: We used both continuous and cat-
egorical variables as they were reported in the EHR, with
the exception of Lead Days-variable (Number of days in
hospital leading up to inclusion). Lead-days had a U-shaped
relationship to several outcome variables, which is why we
created a quintile nominal variable, and included both the
nominal and continuous version in model building. None
of the final main effect 95% CI were unreasonably wide, so
we did not consider collinearity a problem (See Table 3).
We built models according to a general rule set to
minimise the effect of subjective modelling decisions on
results. In a combined stepwise forwards / backwards se-
lection process, we examined the confounding effects of
variables with a statistically significant difference, or a
standardised difference > 0,2 SD between groups and the
three compound variables on resource utilisation [64],
re-admission risk [73], and mortality [74]. For each out-
come, we added the corresponding “before-measure” to
all models. For mortality, there are no before measures,
so we included proxies for death-risk instead: age and
the Elixhauser score [74]. Finally, we added the
matched-triplet-ID as a random-effect variable to adjust
for dependencies caused by matching [71]. The Higgins
I2 statistic [77] showed heterogeneity across study sites,
which is why we added “Site” both as a random and a
fixed effect variable following Cochrane meta-analysis
advice [78]. In sensitivity analyses, data from outlier sites
were omitted to estimate their effect on results [77].
Bias concerns
Controls become eligible upon an emergency hospital
admission while intervention patients become eligible
upon referral to the PACT intervention. We outline the
potential biases due to these differences, and how we
have dealt with them in Table 1.
Presentation of results and software
To explore the bias concerns outlined above, we
made the following sub-group analyses for all out-
comes: 1) Survival and indication bias: Only controls
who survived median lead-days of PACT patients, 2)
Healthy selection bias: Only PACT patients who had
an emergency admission index episode, and 3)
strictest subgroup: a combination of 1 and 2. In the
Table 1 Overview of bias concerns, consequences and adjustments in the PACT intervention study, Norway 2014–16




More patients (69%) in the intervention group than in the control group
(19%) had Lead Days in the hospital before inclusion.
Mortality: Intervention patients must survive lead days to be referred and
included in PACT. Survivors may be healthier and cause a survival bias.
Sum emergency inpatient bed-days: In controls, we count “inpatient days”
from the first day of emergency admission. In PACT patients, we start
counting from the time of referral to PACT, leaving out emergency Lead
days before referral. If left unadjusted, this would bias comparisons towards
a lower sum of emergency days in intervention patients.
Mortality risk analyses:
Restricted sub-group analyses to control-patients with a
survival time equal to or greater than median Lead-days
in the intervention group.
Sum emergency inpatient days:
We adjusted for Lead Days so that effect estimates are
independent of prior lead days. We tried matching on
lead-days, which would be the preferred avenue, but we
could not find enough matching controls for this.
We restricted analyses of sum emergency bed-days to
PACT patients with an index emergency hospitalisation
so that both groups add emergency bed-days from their
index episode to the 6-month outcome measure.
Indication
bias
Referral to the PACT intervention is less likely for terminal patients, or
patients they judge to be unsuitable for the intervention for other reasons.
In the control group, providers are likely to refer all other patients,
including terminal patients to emergency admissions who then become
eligible to be controls. We have no data, on the judgements made by
referring professionals in either group.
Adjustment for possible under-referral of terminal
patients to the intervention: We used the Elixhauser
death risk score and the modified (m)-PARR30 score for
both matching and adjustment. The C-statistic was 0,74
and 0,71 for death within six months in a local hospital
population for these two predictors respectively.
We made sub-group analyses restricted to control-
patients who survived median Lead-days to exclude
terminal controls who died in their first few days in the
hospital.
We estimated crude mortality risk in intervention patients





69% of the intervention and 100% of the control patient index episodes
were linked to an emergency admission. Intervention patients who had no
index-episode emergency hospitalisation may be healthier than controls.
Sub-group analyses restricted to intervention patients
whose index episode was an emergency admission.
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abstract and results, we focus on multivariate-ad-
justed rate ratios (RR = Intervention Rate/ Control
Rate) from the strictest sub-group analysis, as these
represent our most unbiased effect estimates. We
present results for other groups in Table 3.
The SNOW system© [79] extracted data from the EHR
for us. We used MatchIT v 2.4–21© [70] for PS-matching.
We used Stata© v 14.0 and 15.0 for statistical analyses.
We calculated heterogeneity I2 with "Comprehensive
Meta-Analysis Version 3.0© [80].
Results
Exclusions, balance between groups and study
population
530 persons were referred to the PACT-intervention
for 606 care episodes from Oct. 2014 – Sept. 2016.
The PACT-referral review team declined 5 % of re-
ferrals. Figure 1 shows the exclusion flowchart. 83%
of all referred and 94% of all eligible persons con-
tributed to final analyses.
The dataset showed an excellent balance, with no bal-
ance tests outside of the recommended range. Some of
the matching variables differed significantly between
groups (see Table 2). As expected, the distribution of
Lead days, which we were unable to match for, differs
between groups.
Hypothesis 1: reduction in emergency care utilisation
All adjusted RR indicated a reduction of high-level emer-
gency care utilisation.
In our strictest sub-group analysis, RR for emergency ad-
missions was 0.90 (95%CI: 0.82–0.99), RR for sum emer-
gency bed days was 0.68 (95%CI: 0.52–0.79) and RR for 30-
days readmissions 0.72 (95%CI: 0.41–1.24). See Table 3 for
details of multivariate analyses in other groups.
Hypothesis 2: increased utilisation of low-level planned
care
The adjusted RR indicated a substantial increase in
planned low-level care and no change in low-level emer-
gency care.
Fig. 1 Inclusion and exclusion Flowchart. Legend: The figure shows eligible PACT patients and exclusions at the person level. The Patient-Centred
Team (PACT)-study, Norway 2014–16
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The RR for planned outpatient visits was 2.3
(95%CI: 2.02–2.55), while RR for emergency out-
patient visits was 0.9 (95%CI: 0.68–1.20) in our strict-
est sub-group analysis. Please see Table 3 for details
of multivariate analyses in other groups.
Hypothesis 3: unchanged mortality rates
The adjusted RR indicated a reduction in mortality risk
at both three and six months follow-up.
In all, 74 (17%) and 180 (23%) patients died within
the 6-month follow-up in the intervention and
control group respectively. The median survival time
in both the control and intervention groups was
182.5 days (5–95%-tile Controls: 12–182.5, PACT:
35–182.5, p = 0.009).
The RR for death at three months was 0.39 (95% CI:
0.22–0.70) in our strictest sub-group analysis. The protec-
tion waned somewhat after three months so that at six
months the RR was 0.57 (95% CI: 0.34–0.94), also in our
strictest sub-group analysis. Please see Table 3 for details of
multivariate analyses for other groups. The Kaplan–Meier
plot shows a net survival benefit in the intervention groups
by the end of the follow-up period (Fig. 2).
There were in all 28 referred patients who did not get
the PACT intervention within 24 h and were therefore
ineligible for analyses. Of these 6 (21%) died. There were
in all 4 (15%) deaths among the 26 persons who did re-
ceive the intervention but were excluded from analyses
due to technical reasons (no prior hospital history, no
suitable match). Small numbers preclude drawing any
conclusion from these numbers.
Table 2 Background variables and balance. Crude descriptive measures at baseline, for participants and their matched controls. If
not otherwise marked, the point estimate is median and dispersion 5–95%-tile. All variables in the table were matching variables,
except for the two Lead Days variables. The Patient-Centred Team (PACT)-study, Norway 2014–16
Controls Intervention p
Unit N Point estimate Dispersion N Point estimate Dispersion
Sex (%) male 779 41% NA 439 41% NA 0.51
Year at inclusion (%) in 2015 779 51% NA 439 51% NA 0.98
Age (mean/SD) years 779 78.81 8.68 439 80.02 8.72 0.02
m-PARR30. 2Y (mean/SD) Score 779 2.19 0.57 439 2.16 0.61 0.49
DRG points. 1Y Sum 779 2.20 0.03–12.65 439 2.70 0.32–14.79 0.10
# Main diagnoses, 1Y Count 779 3 1–8 439 3 0–8 0.30
# Bi-diagnoses 1Y Count 779 3 0–13 439 3 0–12 0.05
# Long-term Diagnoses. Count 779 11 2–29 439 11 3–28 0.41
m-PARR30, 2Y Score 779 2.15 1.30–3.16 439 2.09 1.33–3.20 0.10
Elixhauser, 2Y Score 779 5 0–20 439 5 0–20 0.28
Emergency Inpt Adm. 1Y Count 779 2 0–8 439 1 0–7 0.05
Emergency Inpt Adm, 30d Count 779 1 0–4 439 1 0–2 0.96
Emergency Bed days, 30d Sum 779 2 0–15 439 3 0–16 0.03
Emergency Bed days, 1Y Sum 779 6 0–52 439 6 0–55 0.86
Emergency Outpt visit, 30d Count 779 0 0–1 439 0 0–1 0.43
Emergency Outpt visit, 1Y Count 779 0 0–3 439 0 0–3 0.95
30d Readmissions, 1Y Count 779 0 0–1 439 0 0–2 0.26
Planned Inpt Adm, 1Y Count 779 0 0–4 439 0 0–2 0.04
Planned Inpt Adm 30d Count 779 0 0–1 439 0 0–1 0.74
Planned Outpt visit, 1Y Count 779 2 0–21 439 2 0–18 0.22
Planned Outpt visit, 30D Count 779 0 0–3 439 0 0–3 0.06
Lead Days Count 779 0 0–9 439 4 0–30 < 0.001
Quintile Lead Days (%) Q 1 + 2 779 78% NA 439 20% NA < 0.001
Abbreviations: N Number of patients, # Number of, p-probability, SD Standard deviation, m-PARR30 modified PARR score [76], Elixhauser score – Elixhauser
Comorbidity Measure [77], DRG Diagnosis Related Groups [64], Readmissions – New emergency admission within 30 days of last hospital discharge, Inpt Inpatient,
Adm Admission, Outpt Outpatient. Main-diagnosis: The current diagnosis which caused admission. Bi-diagnoses: Other diagnoses relevant for the care of the
current problem
Time spans: 1Y - Last year prior, 2Y – Last 2 years prior, 30d – Last 30 days prior
Statistics: P-values for two-sided t-tests (continuous normal variables) Wilcoxon rank-sum test (continuous non-normal variables) and Chi2-test (discrete variables)
for difference between control and intervention groups
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Table 3 Rate Ratios for outcomes: Multivariate multilevel adjusted pooled analysis, at six months follow-up, by outcomes and sub-
group. Negative Binomial regression for health care utilisation outcomes and Cox regression for mortality. The Patient-Centred Team
(PACT)-study, Norway 2014–16
Outcome Population sub-groups N RR p 95% CI
Lower Upper
Count, Emergency Admissions after
index episode
All, adjusted 1218 0.95 < 0.001 0.94 0.96
Only controls surviving Lead days (1) 1195 0.95 0.024 0.91 0.99
Only PACT patients with index emergency
hospitalizations (2)
856 0.90 0.018 0.82 0.98
Combination of 1 and 2 838 0.90 0.033 0.82 0.99
Sum, Emergency Bed days (including
index episode bed days)
Only PACT patients with index emergency
hospitalizations (2)
856 0.62 < 0.001 0.49 0.77
Combination of 1 and 2 838 0.68 0.005 0.52 0.89
Count, emergency readmissions within
30 days of discharge, after index episode
All, adjusted 1218 0.64 < 0.001 0.52 0.78
Only controls surviving Lead days(2) 1195 0.63 < 0.001 0.51 0.79
Only PACT patients with index emergency
hospitalizations (2)
856 0.71 0.213 0.41 1.22
Combination of 1 and 2 838 0.72 0.231 0.41 1.24
Count, Planned outpatient visits All, adjusted 1218 2.40 < 0.001 2.21 2.61
Only controls surviving Lead days(1) 1195 2.41 < 0.001 2.22 2.62
Only PACT patients with index emergency
hospitalizations (2)
856 2.26 < 0.001 2.01 2.54
Combination of 1 and 2 838 2.27 < 0.001 2.02 2.55
Count, Emergency Outpatient visits All, adjusted 1218 0.82 0.001 0.73 0.92
Only controls surviving Lead days(1) 1195 0.82 < 0.001 0.76 0.88
Only PACT patients with index emergency
hospitalizations (2)
856 0.89 0.408 0.67 1.18
Combination of 1 and 2 838 0.90 0.464 0.68 1.20
Mortality 0–3 months All, adjusted 1218 0.38 < 0.001 0.24 0.60
Only controls surviving Lead days(1) 1195 0.46 0.001 0.28 0.73
Only PACT patients with index emergency
hospitalizations (2)
856 0.32 < 0.001 0.19 0.55
Combination of 1 and 2 838 0.39 0.001 0.22 0.70
Mortality 0–6 months All, adjusted 1218 0.53 0.001 0.37 0.77
Only controls surviving Lead days(1) 1195 0.60 0.010 0.41 0.89
Only PACT patients with index emergency
hospitalizations (2)
856 0.48 0.003 0.30 0.78
Combination of 1 and 2 838 0.57 0.028 0.34 0.94
Abbreviations: N Number of patients, RR Rate Ratio (Rate Interv /Rate Control), p probability, 95% CI 95% confidence interval
Sub-group analyses: (1) Only controls surviving Lead days: Controls who survived the intervention group’s median lead days in the hospital. Excluded: Controls
who died during the first 4-5 days and their matches. (2) Only intervention patients with an index emergency hospital episode. Excluded: Intervention patients
with index episode in the municipality or planned hospitalisation and their matches
Final model adjustment variables: Emergency admissions: Fixed effect: Count of emergency admissions last year, Site. Random effect: site, triplet-stratum ID.
Final model adjustment variables: Sum emergency inpatient days: Fixed effect: Quintile of lead days, Sum emergency bed days last year, Site. Random effect: site,
triplet-stratum ID
Final model adjustment variables: Count 30-day Readmissions: Fixed effect: Quintile of lead days, Count re-admissions last year, Site. Random effect: site, triplet-
stratum ID.
Final model adjustment variables: Planned outpatient visits: Fixed effect: Count planned outpatient visits last year, Site. Random effect: site, triplet-stratum ID
Final model adjustment variables: Emergency outpatient visits: Fixed effect: Quintile lead days, Count emergency outpatient visits last year, Site. Random effect:
site, triplet-stratum ID
Final model adjustment variables: Mortality 0-3 months: Fixed effects: Quintile lead days, Age, Elixhauser score, Site. Random effect: site, triplet-stratum ID
Final model adjustment variables: Mortality 0-6 months: Fixed effects: Quintile lead days, Count readmission last year, Age, Elixhauser score, Site. Random effect:
site, triplet-stratum ID
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Sub-group and sensitivity analyses
Survival and indication bias
When we compared RRs of “All, adjusted” with that
of “Only controls surviving Lead days” we saw a
weakening of the three month RR mortality from 0,
38 to 0,46 (Δ16%) and six month RR from 0,53 to 0,
66 (Δ11%) (Table 3). The result implies survival and
indication bias, but the intervention effect was still
substantial. A Kaplan Meier plot of the strictest sub-
group, excluding outlier sites also showed a net
benefit for the intervention group. (See Additional
file 2) No other outcome changed > 10%.
Healthy selection bias
We saw a strengthening of the three month RR estimate
from 0,38 to 0,32 (Δ19%) when comparing RRs for “All”
with “Only index emergency hospitalisations” (Table 3).
The finding weakens the case for healthy selection bias.
No other outcome changed > 10%.
Lead time bias
The crude RR estimate of sum-emergency days changed
direction from a crude RR of 1.1 to an adjusted RR of 0.58
upon adjustment for Lead days, showing Lead days to be a
strong confounder for this outcome (data not shown).
Heterogeneity and interactions with site
There was no evidence of interaction across
intervention sites, as the interaction term between
intervention site and outcome were not significant
for any outcomes (data not shown). Except for 30-
day readmissions, all outcomes displayed significant
heterogeneity across control sites, but the control
sites took turns in being the outlier for each out-
come (See Additional file 2). Exclusion of outlier
sites changed the 6 month mortality RR point
estimates for one sub-group analysis: “Only index
emergency hospitalisations” from a RR of 0,48 (p = 0,
003) to a RR of 0,54 (p = 0,01) (Δ11%). No other
outcomes changed > 10%.
Discussion
Principal findings
Compared with propensity score matched controls, the
care process of frail multi-morbid elderly who received
the PACT intervention had a reduced risk of high-level
emergency care, increased use of low-level planned care,
and substantially reduced mortality risk.
Strengths and weaknesses
Internal validity
As administrative personnel was unaware of the treat-
ment status, systematic misclassification of outcomes is
unlikely. The high degree of completeness of data makes
missing outcomes a negligible problem [65], and
strengthens internal validity.
Bias evaluation: We have discussed some possible
biases that might have influenced our analysis. Admit-
tedly, analyses restricted to controls who had survived
the median lead-time showed a weaker, albeit still sig-
nificant mortality risk reduction. It is relevant to point
out that this sub-group analysis is, an “over-correction”
because by definition half of the intervention patients
will have survived a shorter lead-time than the median,
whereas all the controls survived the lead-time period.
The strictest sub-group analysis, combining adjustment
Fig. 2 Mortality. Legend: Crude Kaplan-Meier curves, showing the proportion of patients alive by time, and group in 6 months follow-up period.
Pooled data, (N = 1218). The Patient-Centred Team (PACT)-study, Norway 2014–16
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for both indication and healthy selection bias, did not
erase our findings.
We are naturally unable to account for unknown biases
or confounding, as they would have been in an RCT. We
have no systematic review of referral practices. The care
process documentation is limited to changes in the health
care utilisation outcomes, which did support our hypoth-
eses, although a more detailed process evaluation is called
for. Both challenges are limitations, and areas for future
research (see below).
External validity
Non-parametric pre-processing by use of propensity
score matching allows a post hoc creation of a control
group and reduces model dependencies [81]. Although
considered to have a lower internal validity than an
RCT, its applicability to “real world” data gives a higher
external validity [82]. The balance measures were excel-
lent, warranting comparability between groups on all
known variables. The matching software program
(MatchIt) had no access to follow-up data, which en-
sured that matching was not influenced by outcomes
data, which is a critique towards this methodology [83].
Since we were granted permission to extract routine
data without formal consent, we were able to include
both patients with cognitive impairment and/ or acute
morbidity. Both conditions contribute to the underrepre-
sentation of elderly in clinical research [84]. Exclusions
of these highly vulnerable patients from outcomes evalu-
ations, represent an ethical challenge, as these popula-
tions have an equal right to quality assurance and
evaluation of care as other patient groups [84].
Norwegian health care constitutes its own context,
which probably differs from that of other countries in
important respects. We have one study that shows low
integration of care in Norway [40]. The context depend-
ency is an area worthy of further research (see below).
Within Norway, we implemented the intervention at
two sites and found no interactions by Site. Effects did
vary by control-context, but the intervention effect was
significant even after we had adjusted for control-site
variation as a random effect. The study has high external
validity, which is a strength.
PACT results in light of literature
PACT compared to other goal-oriented PCC interventions
The Goal-oriented PCC care of PACT has still no inter-
nationally recognised vocabulary. However, similar ap-
proaches are “flipped care” [30], and “personalised care
planning” [15]. Their commonality is the construction of
personalised goals together with the patient, which sub-
sequently drives care planning, care delivery, and care
evaluation. “What matters” is the organising principle of
care, inescapably present throughout the entire care
process. Our PCC approach differs fundamentally from
other person-centred approaches linked to integrated
care, where authors often describe tailoring of care plans
to personal values, needs, and preferences, yet they fail
to show how plans, care delivery and evaluation become
shaped by the person’s goals [15].
We have found only one controlled clinical trial di-
rected at persons with CLNs which applies “flipped
healthcare” similarly to us. Sweeney compared a “Pa-
tient-Centred management” with usual case-manage-
ment for cancer patients at the end of life and found
reduced care utilisation and costs, with no shortening of
life [85]. Coulter’s Cochrane review on personalised care
planning reports a small but significant improvement in
bio-psycho-medical health, which “… appear greater
when the intervention is more comprehensive, more in-
tensive, and better integrated into routine care.” How-
ever, she found no eligible studies on multi-morbidity in
the review, which makes her promising findings tangen-
tial to our work. Two protocols that subscribe to a goal-
oriented PCC care process show that Goal-PCC is an up
and coming concept [86, 87].
PACT compared to interventions aligned with the chronic
care model
We also compared PACT with comprehensive care in-
terventions directed at persons with CLNs, defined as at
least two components of the Chronic Care Model
(CCM) [16]. Of 15 studies that reported mortality risk, 3
reduced mortality significantly [88–90]. Two of the three
studies are from Norway [89, 90]. In a comparative study
across 11 nations on gaps in care integration, Norway
performed poorly [40]. As there is a lack of follow-up
studies, at this stage we can only speculate on whether
this is why the Norwegian context seems to be more re-
sponsive to comprehensive care interventions. However,
it is difficult to see any clear pattern of how the three
positive studies differ from the 12 negative studies. de
Bruin concluded in her review that “No evidence was
found for a beneficial effect of comprehensive care on (
…) mortality.” de Bruin also notes the diversity in effects
from comprehensive care programs, and links it to the
variation in interventions and context [16].
We found two other studies that resembles the PACT
study, in that they apply a three-component PCC, inte-
grated and pro-active care model. Yet neither of these
had paid close attention to the synergies between the
three elements. Neither study showed any effects on
hospital health care utilization, costs or function. This is
in line with several recent reviews of multi-component
comprehensive care models designed to address the
challenges of multi-morbidity or frail patients, where the
results across studies are mixed [21, 22, 91–93]. The re-
views lament the heterogeneity of both target groups
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and intervention designs. We believe a careful untan-
gling of the desired goals, and the chain of causes and
effects that lead to the desired goal at both population
and individual levels are not yet well enough
understood.
PACT mechanisms for effect
The PACT intervention did not introduce any new bio-
logical treatments. The mechanisms for a mortality differ-
ence between the groups must either be the result of bias
between the groups, the result of the intervention or a com-
bination of both. While we have discussed possible biases
at great length above, we here present some of the mecha-
nisms of the intervention, which we hypothesise, might
contribute to our results.
 Patient detected quality challenges: The
continuous dialogue with the patient on “what
matters to you” give insights into challenges that
only the patient can detect, and allows the team to
address them effectively. Examples are gaps in care,
where delivery of planned care failed, such as
missing referrals or missing prescriptions, adverse
events that could influence patient willingness to
follow self-management advice, i.e. a hypoglycemic
episode following recommended exercise, or
ineffective pain management, which hinders mobility
training.
 Proactive care planning: Comprehensive geriatric
assessment includes an early evaluation and
management of common geriatric complaints, such
as exercises in sarcopenia, and effective under-
nourishment management [63]. We added several
complementary risk-management strategies, (see
intervention design) designed to stabilise the health
situation and prevent further clinical crises.
 Avoid iatrogenic disability: frail elderly are
vulnerable, at risk for a large fall in function
following minor insults [63]. Hospitalization of
elderly patients is associated with delirium,
decreased mobility and increased dependency [94].
PACT works to mitigate decompensation through
early discharge to a familiar environment.
 Prescription review: performed by the pharmacist
revealed errors and interactions in a majority of the
medication lists reviewed. The pharmacist corrected
such errors in collaboration with the relevant
professionals.
 Improved care delivery according to plan: Due to
fragmented information and organisational systems,
professionals have few tools to support the
interdisciplinary dialogue and collaboration.
Typically, no professional will have the full overview
of the needs or activities for patients with CLNs.
Gaps and overlaps are virtually “invisible” in a silo-
based system. The PACT team has the time and
capacity to make an overview of all care, facilitate
dialogue across organisations and professions and
continuously update all parties involved in the care
plan. PACT ensures that the care plan aligns with
the patient’s personal goals, planned activities are
not at odds with one another, and care plans
translate into actual care delivery.
 Professional motivation: The goal-oriented PCC
serves to make all parties work towards the same
goal. It not only makes sense to the person who
needs care. Working together with the patient
towards “What matters” seems to have a substantial
motivational effect on involved professionals across
organisations in the primary and second care sector
[32]. PACT team members feel they are “making a
difference”, which may in itself influence outcomes.
 Flexible and adaptive goal driven care: Finally,
PACT does not force care planning into a specific
method or format. Instead, the agents follow a set of
principles and pragmatically apply them to reach the
negotiated goals. We hypothesise that this flexibility
allows the partners to create tailored solutions,
which may be more effective than multiple un-
coordinated standardised pathways for multi-morbid
patients [26].
PACT builds on real-world data, has shown transferabil-
ity across two intervention sites, and produce consistent
results across control sites. The PACT project aimed to
remedy universally acknowledged challenges [1–4]. Our
health care utilisation measures show that PACT suc-
ceeds in reducing the emergency care and increase
planned low-level planned care. Our underlying hypoth-
eses for why our intervention works are in accord with
the literature [9–14]. To summarise, the substantial ef-
fects of the “real world” PACT study, concerning both
mortality and health service utilisation is unusual.
Implications for practice and further research
Several comparable interventions in the literature pro-
actively identify frail patients in GP EHR, but these stud-
ies fail to show effects [95, 96]. It may be, that it is not
enough to capture frailty, as some very frail persons may
be balancing their lives well enough, and interventions
may upset their precarious balance. Finding formal
methods of capturing the frail person as they move to an
unstable state, while there is still time to regain balance,
is an important research question. A formal definition of
the PACT target population would also allow us to
evaluate how outcomes for a formally identified frail eld-
erly in intervention municipalities compared to the same
group in control municipalities.
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To further examine external validity in an inter-
national context, a comparison of the Norwegian results
with international propensity score matched control-
groups is an aim for future research.
Although we attribute effects to our theoretical under-
pinnings, the study merits further evaluation of the
causes of death in the two treatment groups, to under-
stand better how effects are produced [97]. A stronger
understanding of the care process and mechanisms of ef-
fect and how patient pathways differ between groups
and contexts would help us understand which compo-
nents require high fidelity in any intervention site, and
which components can and should tailor to the local
context.
Conclusions
The PACT intervention lowers the need for high-re-
source emergency care, increases use of planned low-re-
source care and protects vulnerable patients from death
compared to propensity score matched controls. We
have used a robust methodology and have adequate stat-
istical power to support our findings. The PACT study
has designed a person-centred, integrated and pro-active
care model, which attends to, responds to and is loyal to
“what matters to you?”, using the cyclical goal-oriented
adaptive solving strategies from complexity theory. We
argue that our study is a contribution towards a better
understanding of care for persons with CLNs. Further
studies of the effects of goal-oriented PCC may force the
highly needed paradigm shift that will make genuine
goal driven PCC the norm.
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devices/ computers. Only 3 researchers (GB, JH, TB1) had access to the
analysis files. All intermediate and final results were fully anonymized.
We report here on secondary outcomes extracted from the EHR: Mortality
and health services utilization. The first EHR data were extracted in Jan 2016
after we had obtained necessary formal approvals from REC and the privacy
ombudsman.
Consent to publish from individual participant data is not applicable to this
paper.
We continue a consent based collection of Patient reported outcome
measures. We enrolled the first patient for PROMs in Nov 2015, which is our
primary outcome according to the published protocol. PROMs collection will
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